Morning Briefing
Summaries of health policy coverage from major news organizations
Reuters Examines Development Progress Of Microbicide Gel To Prevent HIV
Reuters reports that the developers of a vaginal microbicide gel containing the antiretroviral tenofovir which has been found to reduce "HIV infections in women by 39 percent," said that during meetings last week the U.S. Food and Drug Administration (FDA) granted fast track approval designation to the gel, which expedites the review of drugs by the agency.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
